Rory Collins

Q: What Schools Are Affiliated With Rory Collins

Rory Collins is affiliated with the following schools: University of Oxford, University of Edinburgh, Karolinska Institute

Rory Collins's AcademicInfluence.com Rankings

Rory Collins

Medical

#292

World Rank

#430

Historical Rank

Public Health

#53

World Rank

#54

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Rory Collins Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sir Rory Edwards Collins FMedSci FRS is a British physician who is Professor of Medicine and Epidemiology at the Clinical Trial Service Unit within the University of Oxford, the head of the Nuffield Department of Population Health and a Fellow of Green Templeton College, Oxford. His work has been in the establishment of large-scale epidemiological studies of the causes, prevention and treatment of heart attacks, other vascular disease, and cancer, while also being closely involved in developing approaches to the combination of results from related studies . Since September 2005, he has been the Principal Investigator and Chief Executive of the UK Biobank, a prospective study of 500,000 British people aged 40–69 at recruitment.

(See a Problem?)

Rory Collins's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (2002) (8824)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005) (6940)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins (2005) (6375)
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients (2002) (5918)
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. (1998) (5391)
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age (2015) (5094)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials (2005) (4770)
Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias (1990) (4608)
Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context (1990) (4606)
Tamoxifen for early breast cancer: an overview of the randomised trials (1998) (3764)
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients (1994) (3667)
Beta blockade during and after myocardial infarction: an overview of the randomized trials. (1985) (3268)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. (2010) (3183)
Polychemotherapy for early breast cancer: an overview of the randomised trials (1998) (2983)
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial (2003) (2829)
Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. (1988) (2755)
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. (2009) (2583)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial (2003) (2437)
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer (1997) (2362)
Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. (1998) (2171)
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths (2007) (2162)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri (2005) (2151)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial (2011) (2093)
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis (2010) (1950)
Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. (2002) (1883)
Diabetes mellitus, fasting glucose, and risk of cause-specific death. (2011) (1874)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. (2009) (1857)
Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial (2005) (1827)
SLCO1B1 variants and statin-induced myopathy--a genomewide study. (2008) (1819)
Defining the role of common variation in the genomic and biological architecture of adult human height (2014) (1805)
ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction (1995) (1755)
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. (2008) (1647)
Newly identified loci that influence lipid concentrations and risk of coronary artery disease (2008) (1626)
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke (1997) (1615)
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial (2013) (1615)
Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population (2017) (1599)
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents (2016) (1582)
A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease (2015) (1567)
Major lipids, apolipoproteins, and risk of vascular disease. (2009) (1563)
Large-scale association analysis identifies new risk loci for coronary artery disease (2012) (1507)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. (2012) (1436)
Common variants at 30 loci contribute to polygenic dyslipidemia (2009) (1380)
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. (2009) (1329)
Interpretation of the evidence for the efficacy and safety of statin therapy (2016) (1290)
Chronic infections and coronary heart disease: is there a link? (1997) (1289)
Genetic variants associated with Lp(a) lipoprotein level and coronary disease. (2009) (1242)
Effects of extended-release niacin with laropiprant in high-risk patients. (2014) (1242)
Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies (1996) (1205)
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. (2005) (1195)
Randomised trial of prophylactic daily aspirin in British male doctors (1988) (1160)
Multimodal population brain imaging in the UK Biobank prospective epidemiological study (2016) (1117)
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions (2004) (1066)
Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. (1988) (1058)
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial (2002) (1021)
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials (2015) (999)
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial (2000) (962)
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women (1992) (951)
Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies (2000) (934)
ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION (1992) (920)
Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial (2012) (918)
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women (1994) (889)
Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial (2005) (853)
Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women (1988) (842)
Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials (2000) (809)
Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease (2002) (781)
EFFECTS OF RADIOTHERAPY AND SURGERY IN EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS (1995) (767)
Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. (1999) (765)
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies (2012) (745)
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus (2018) (735)
Association of apolipoprotein E genotypes with lipid levels and coronary risk. (2007) (731)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial (2017) (713)
Why do we need some large, simple randomized trials? (1984) (706)
Unravelling the fetal origins hypothesis: is there really an inverse association between birthweight and subsequent blood pressure? (2002) (697)
Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. (1992) (671)
WHICH ANTICONVULSANT FOR WOMEN WITH ECLAMPSIA - EVIDENCE FROM THE COLLABORATIVE ECLAMPSIA TRIAL (1995) (665)
A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease (2011) (638)
Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. (1998) (632)
Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. (2009) (614)
Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. (1994) (607)
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment (2013) (605)
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment (2013) (605)
China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. (2011) (592)
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. (2011) (589)
Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies (2010) (588)
Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. (1991) (585)
What makes UK Biobank special? (2012) (581)
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. (1985) (564)
Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. (2000) (528)
Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. (2008) (527)
Ovarian ablation in early breast cancer: overview of the randomised trials (1996) (518)
Randomised controlled trial to compare surgical stabilisation of the lumbar spine with an intensive rehabilitation programme for patients with chronic low back pain: the MRC spine stabilisation trial (2005) (499)
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. (2010) (477)
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England (2020) (464)
Heart Protection Study (2003) (461)
Effects of n‐3 Fatty Acid Supplements in Diabetes Mellitus (2018) (441)
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks (2018) (435)
Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin (1989) (434)
Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. (2005) (427)
ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither (1998) (422)
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66 155 cases and 91 307 controls (2006) (417)
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). (2005) (400)
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function (2016) (388)
Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls (1999) (381)
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (2019) (377)
Large-scale randomized evidence: large, simple trials and overviews of trials. (1993) (375)
UK Biobank: Current status and what it means for epidemiology (2012) (362)
Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence (2019) (350)
Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. (1991) (338)
Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. (2000) (336)
EFFECT OF INTRAVENOUS NITRATES ON MORTALITY IN ACUTE MYOCARDIAL INFARCTION: AN OVERVIEW OF THE RANDOMISED TRIALS (1988) (329)
Is birth weight a risk factor for ischemic heart disease in later life? (2007) (323)
Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials (2001) (320)
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. (2010) (314)
Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. (2010) (311)
Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. (1988) (307)
Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals (2013) (301)
Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies (2015) (301)
Cohort profile: the Kadoorie Study of Chronic Disease in China (KSCDC). (2005) (301)
Four paraoxonase gene polymorphisms in 11 212 cases of coronary heart disease and 12 786 controls: meta-analysis of 43 studies (2004) (300)
Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. (2005) (298)
Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. (1997) (297)
Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China (2017) (296)
The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China. (2016) (293)
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy (2012) (293)
Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation (2015) (285)
A comparison of the early outcome of acute myocardial infarction in women and men. The Third International Study of Infarct Survival Collaborative Group. (1998) (277)
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial (2001) (271)
Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials. (1985) (263)
UK Biobank’s cardiovascular magnetic resonance protocol (2015) (260)
Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin: Overview of Results of Randomized Trials in General, Orthopedic, and Urologic Surgery (1989) (259)
Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China (2019) (253)
Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1) (1995) (247)
Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke (2018) (239)
Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies (2001) (236)
The Magic of Randomization versus the Myth of Real-World Evidence. (2020) (235)
Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data (2019) (231)
Randomized, Double-blind Comparison of Hirulog Versus Heparin in Patients Receiving Streptokinase and Aspirin for Acute Myocardial Infarction (HERO) (1997) (229)
Large-Scale Gene-Centric Analysis Identifies Novel Variants for Coronary Artery Disease (2011) (228)
Fresh Fruit Consumption and Major Cardiovascular Disease in China. (2016) (220)
Genetically determined height and coronary artery disease. (2015) (220)
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) (2009) (219)
Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data (2018) (217)
Physical activity and sedentary leisure time and their associations with BMI, waist circumference, and percentage body fat in 0.5 million adults: the China Kadoorie Biobank study. (2013) (212)
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. (2016) (207)
The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions (2020) (206)
A statin-dependent QTL for GATM expression is associated with statin-induced myopathy (2013) (206)
UK Biobank Data: Come and Get It (2014) (203)
Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches (2013) (201)
Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review (2002) (198)
Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials (1996) (197)
Diabetes and Cause-Specific Mortality in Mexico City. (2016) (197)
Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study (2012) (195)
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease. (2005) (189)
Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study (2011) (185)
Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies (2012) (182)
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) (181)
Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14,000 cases and 32,000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators. (1995) (180)
Homocysteine and Coronary Heart Disease: Meta-analysis of MTHFR Case-Control Studies, Avoiding Publication Bias (2012) (180)
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase (2017) (174)
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial (2011) (174)
Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals12345 (2014) (173)
Seasonal variation in blood pressure and its relationship with outdoor temperature in 10 diverse regions of China: the China Kadoorie Biobank (2012) (173)
Cigarette smoking, tar yields, and non-fatal myocardial infarction : 14000 cases and 32000 controls in the United Kingdom (1995) (169)
Birth weight and subsequent cholesterol levels: exploration of the "fetal origins" hypothesis. (2004) (167)
A Comparison of the Early Outcome of Acute Myocardial Infarction in Women and Men (1998) (166)
Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre‐eclampsia and its complications (1998) (165)
Early health effects of the emerging tobacco epidemic in China. A 16-year prospective study. (1997) (162)
Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collab (2000) (161)
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study (2021) (160)
Statins and diabetes – Authors' reply (2008) (160)
Breast cancer and hormonal contraceptives: further results (1996) (158)
Sensible approaches for reducing clinical trial costs (2008) (156)
Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'. (2006) (156)
MRC BHFHeart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience (1999) (156)
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases (2007) (155)
Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial. (2006) (154)
Perioperative Rosuvastatin in Cardiac Surgery. (2016) (151)
Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study (1999) (147)
Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults (2019) (147)
Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation (2001) (140)
Stability of plasma analytes after delayed separation of whole blood: implications for epidemiological studies. (2003) (134)
Can Dietary Supplements with Folic Acid or Vitamin B6 Reduce Cardiovascular Risk? Design of Clinical Trials to Test the Homocysteine Hypothesis of Vascular Disease (1998) (133)
Age-specific relevance of usual blood pressure to vascular mortality (2003) (133)
Early diagnostic efficiency of cardiac troponin I and Troponin T for acute myocardial infarction. (1997) (132)
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase (2018) (130)
The MRC/BHF Heart Protection Study: preliminary results. (2002) (128)
Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20 536 individuals (2005) (126)
Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. (1996) (125)
Outdoor temperature, blood pressure, and cardiovascular disease mortality among 23 000 individuals with diagnosed cardiovascular diseases from China (2015) (124)
Statins for people at low risk of cardiovascular disease – Authors' reply (2012) (123)
N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study. (2007) (122)
ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women (1996) (115)
Novel Associations of CPS1, MUT, NOX4, and DPEP1 With Plasma Homocysteine in a Healthy Population: A Genome-Wide Evaluation of 13 974 Participants in the Women’s Genome Health Study (2009) (115)
Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies (2018) (115)
The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls† (2009) (114)
CHOLESTEROL-LOWERING TRIAL RESULTS IN THEIR EPIDEMIOLOGIC CONTEXT (1985) (114)
Morning peak in the incidence of myocardial infarction: experience in the ISIS-2 trial. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. (1992) (111)
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study. (2011) (111)
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD. (2006) (108)
New Models for Large Prospective Studies: Is There a Better Way? (2012) (107)
Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis (2015) (106)
Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors. (2007) (106)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised controlled trials of statins (vol 366, pg 1267, 2005) (2008) (104)
Genome-Wide Mapping of Susceptibility to Coronary Artery Disease Identifies a Novel Replicated Locus on Chromosome 17 (2006) (102)
The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure. (2008) (101)
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes (2008) (101)
Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy (1995) (100)
Analyses of cancer data from three ezetimibe trials. (2008) (100)
Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20 536 people (2006) (100)
Age-specific association between blood pressure and vascular and non-vascular chronic diseases in 0·5 million adults in China: a prospective cohort study (2018) (100)
Age-specific association between blood pressure and vascular and non-vascular chronic diseases in 0·5 million adults in China: a prospective cohort study (2018) (100)
Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. (1998) (99)
UK Biobank: opportunities for cardiovascular research (2017) (98)
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding (1997) (98)
Randomized clinical trials--removing unnecessary obstacles. (2013) (97)
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study (2012) (97)
Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults (2020) (97)
Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults (2020) (97)
Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study. (1994) (95)
Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deaths. (2013) (94)
Fresh fruit consumption in relation to incident diabetes and diabetic vascular complications: A 7-y prospective study of 0.5 million Chinese adults (2017) (94)
Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. (2012) (93)
Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration (1996) (91)
Association of Physical Activity With Risk of Major Cardiovascular Diseases in Chinese Men and Women (2017) (91)
Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men. (2007) (90)
A Prospective Study of Helicobacter pylori Seropositivity and the Risk for Future Myocardial Infarction among Socioeconomically Similar U.S. Men (2001) (89)
Brain imaging before and after COVID-19 in UK Biobank (2021) (88)
Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial (2018) (87)
Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity (2021) (85)
Feasibility of MR-Based Body Composition Analysis in Large Scale Population Studies (2016) (84)
Lymphotoxin-α Gene and Risk of Myocardial Infarction in 6,928 Cases and 2,712 Controls in the ISIS Case-Control Study (2006) (83)
Alcohol consumption in 0.5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates (2013) (80)
Alcohol consumption in 0.5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates (2013) (80)
Alcohol consumption in 0.5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates (2017) (80)
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes (2017) (79)
Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration. (1995) (79)
Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials (1994) (79)
Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease (2017) (78)
Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group. (1997) (76)
Value of serial myoglobin levels in the early diagnosis of patients admitted for acute myocardial infarction. (1994) (74)
Enhancing the feasibility of large cohort studies. (2010) (74)
Alteplase for Acute Ischemic Stroke: Outcomes by Clinically Important Subgroups in the Third International Stroke Trial (2015) (72)
Emerging Tobacco-Related Cancer Risks in China: A Nationwide, Prospective Study of 0.5 Million Adults (2015) (69)
Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels (2009) (69)
Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk. (2004) (67)
Cholesterol and total mortality: need for larger trials. (1992) (65)
Body Mass Index, Blood Pressure, and Mortality From Stroke: A Nationally Representative Prospective Study of 212 000 Chinese Men (2008) (65)
Effect of Intravenous Nitrates on Mortality in Acute Myocardial Infarction (1993) (63)
Plasma fibrinogen and fibrinogen genotypes in 4685 cases of myocardial infarction and in 6002 controls: Test of causality by "Mendelian randomisation" (2000) (63)
Associations of General and Central Adiposity With Incident Diabetes in Chinese Men and Women (2018) (62)
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021) (60)
No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study. (2011) (60)
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP) (2016) (60)
Plasma phospholipid fatty acids and CHD in older men: Whitehall study of London civil servants (2008) (59)
Prevalence and correlates of airflow obstruction in ∼317 000 never-smokers in China (2014) (59)
British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction. (1991) (58)
Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people (2009) (58)
REDUCTION IN MAJOR MORBIDITY AND MORTALITY BY HEPARIN IN ACUTE MYOCARDIAL-INFARCTION (1989) (57)
Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease (2004) (57)
Body mass index and mortality from ischaemic heart disease in a lean population: 10 year prospective study of 220,000 adult men. (2006) (56)
Paraoxonase polymorphisms and coronary heart disease (2004) (56)
The prevalence of chronic diseases and major disease risk factors at different ages among 150 000 men and women living in Mexico City: cross-sectional analyses of a prospective study (2009) (55)
Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study (2018) (55)
Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases. (2007) (55)
Breastfeeding and the Risk of Maternal Cardiovascular Disease: A Prospective Study of 300 000 Chinese Women (2017) (55)
Cooking fuels and risk of all-cause and cardiopulmonary mortality in urban China: a prospective cohort study (2020) (54)
Lipoprotein(a) Genetic Variants Associated With Coronary and Peripheral Vascular Disease but Not With Stroke Risk in the Heart Protection Study (2011) (53)
MRC/BHF Heart Protection Study (2002) (53)
Sensible guidelines for the conduct of large randomized trials (2008) (53)
Polymorphisms in the WNK1 Gene Are Associated with Blood Pressure Variation and Urinary Potassium Excretion (2009) (52)
Assessing Risk Prediction Models Using Individual Participant Data From Multiple Studies (2013) (52)
Reliable assessment of the effects of treatments on mortality and major morbidity (2007) (52)
Serum cholesterol levels and stroke mortality. (1989) (51)
Novel preservation solution permits 24-hour preservation in rat and baboon cardiac transplant models. (1993) (51)
Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study (2018) (50)
Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. (2008) (50)
SIGNIFICANT REDUCTION IN MORTALITY WITH STREPTOKINASE GIVEN 7-24 HOURS AFTER PAIN ONSET (1988) (50)
Significance of elevated MB isoenzyme with normal creatine kinase in acute myocardial infarction. (1987) (49)
Exhaled carbon monoxide and its associations with smoking, indoor household air pollution and chronic respiratory diseases among 512 000 Chinese adults (2013) (49)
Cohort profile: the Mexico City Prospective Study. (2006) (48)
Smoking and smoking cessation in relation to risk of diabetes in Chinese men and women: a 9-year prospective study of 0·5 million people (2018) (48)
Smoking and smoking cessation in relation to risk of diabetes in Chinese men and women: a 9-year prospective study of 0·5 million people (2018) (48)
Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E ε2/ε3/ε4 genotype (2003) (48)
Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese Adults (2017) (47)
Lipoprotein‐associated phospholipase A2 activity and mass in relation to vascular disease and nonvascular mortality (2010) (47)
Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer. (1993) (46)
Temporal trends of main reproductive characteristics in ten urban and rural regions of China: the China Kadoorie Biobank study of 300 000 women (2014) (46)
High-risk elderly patients PROSPER from cholesterol-lowering therapy (2002) (46)
The advantages of UK Biobank's open‐access strategy for health research (2019) (45)
Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China: China Kadoorie Biobank Study of 0.5 million people☆ (2014) (45)
Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation (2008) (45)
Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease (2014) (45)
Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies (2002) (43)
Effect of temperature and light on the stability of fat-soluble vitamins in whole blood over several days: implications for epidemiological studies. (2004) (43)
Patterns and socio-demographic correlates of domain-specific physical activities and their associations with adiposity in the China Kadoorie Biobank study (2014) (43)
Adherence to a healthy lifestyle and all-cause and cause-specific mortality in Chinese adults: a 10-year prospective study of 0.5 million people (2019) (42)
Blood pressure in relation to general and central adiposity among 500 000 adult Chinese men and women (2015) (42)
Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke (2017) (41)
Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study. (1991) (40)
Blood pressure and coronary heart disease (1990) (40)
Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects. ISIS-4 (Fourth International Study of Infarct Survival) Pilot Study Investigators. (1994) (40)
Adiposity and risk of ischaemic and haemorrhagic stroke in 0·5 million Chinese men and women: a prospective cohort study (2018) (39)
Adiposity and risk of ischaemic and haemorrhagic stroke in 0·5 million Chinese men and women: a prospective cohort study (2018) (39)
[The China Kadoorie Biobank: related methodology and baseline characteristics of the participants]. (2012) (39)
Selection of reperfusion therapy for individual patients with evolving myocardial infarction. (1997) (38)
Depression, anxiety, and prevalent diabetes in the Chinese population: findings from the China Kadoorie Biobank of 0.5 million people. (2013) (37)
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators. (1997) (36)
Large‐Scale Randomized Evidence: Large, Simple Trials and Overviews of Trials (1993) (36)
Vitamin D and cause-specific vascular disease and mortality: a Mendelian randomisation study involving 99,012 Chinese and 106,911 European adults (2019) (36)
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol (2001) (35)
Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis. (2007) (35)
Association of Random Plasma Glucose Levels With the Risk for Cardiovascular Disease Among Chinese Adults Without Known Diabetes. (2016) (34)
Burden of carotid artery atherosclerosis in Chinese adults: Implications for future risk of cardiovascular diseases (2017) (34)
Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose–response meta-analysis (2019) (34)
Adiposity and Blood Pressure in 110 000 Mexican Adults (2017) (33)
Large-scale randomized evidence: trials and overviews. (2008) (33)
Vagal function in relation to gastro-oesophageal reflux and associated motility changes. (1980) (32)
Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14000 cases and 32000 controls in the United Kingdom (1995) (30)
A phenome-wide association study of a lipoprotein-associated phospholipase A2 loss-of-function variant in 90 000 Chinese adults (2016) (29)
Impact of detecting potentially serious incidental findings during multi-modal imaging (2018) (29)
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation (2017) (29)
Fresh fruit consumption and all-cause and cause-specific mortality: findings from the China Kadoorie Biobank (2017) (29)
Is Helicobacter pylori a Factor in Coronary Atherosclerosis? (1999) (29)
The MRC Spine Stabilization Trial: Surgical Methods, Outcomes, Costs, and Complications of Surgical Stabilization (2008) (27)
Hemodynamic effects of captopril and isosorbide mononitrate started early in acute myocardial infarction: a randomized placebo-controlled study. (1993) (27)
Impact of ADCY9 Genotype on Response to Anacetrapib (2019) (27)
Article makes simple errors and could cause unnecessary deaths (2002) (26)
Stroke genetics informs drug discovery and risk prediction across ancestries (2022) (26)
Association of Major Depression With Risk of Ischemic Heart Disease in a Mega‐Cohort of Chinese Adults: The China Kadoorie Biobank Study (2016) (26)
Collaborative overview (‘Meta-Analysis’) of Prospective Observational Studies of the Associations of Usual Blood Pressure and Usual Cholesterol Levels with Common Causes of Death: Protocol for the Second Cycle of the Prospective Studies Collaboration (1999) (26)
The future of humans as model organisms (2018) (25)
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis (2021) (25)
No Association of Coronary Artery Disease with X-Chromosomal Variants in Comprehensive International Meta-Analysis (2016) (25)
Absence of effects of prolonged simvastatin therapy on nocturnal sleep in a large randomized placebo-controlled study. Oxford Cholesterol Study Group. (1996) (25)
Balancing potential risks and benefits of using confidential data (2006) (25)
Antiplatelet therapy to prevent thrombosis after hip fracture. Rationale for a randomised trial. (1994) (25)
Assessment of the Role of Carotid Atherosclerosis in the Association Between Major Cardiovascular Risk Factors and Ischemic Stroke Subtypes (2019) (25)
Regional variations in the prevalence and misdiagnosis of air flow obstruction in China: baseline results from a prospective cohort of the China Kadoorie Biobank (CKB) (2014) (24)
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP) (2016) (24)
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP) (2016) (24)
Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E epsilon2/epsilon3/epsilon4 genotype. (2003) (24)
COPD and its association with smoking in the Mainland China: a cross-sectional analysis of 0.5 million men and women from ten diverse areas (2015) (24)
ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials. (1993) (24)
Lipoprotein-Associated Phospholipase A2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults (2016) (24)
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials (2022) (23)
Protocol for analyses of adverse event data from randomized controlled trials of statin therapy (2016) (23)
Protocol and quality assurance for carotid imaging in 100,000 participants of UK Biobank: development and assessment (2017) (23)
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom (2020) (23)
Risks and Population Burden of Cardiovascular Diseases Associated with Diabetes in China: A Prospective Study of 0.5 Million Adults (2016) (23)
Trust the Blinded Randomized Evidence That Statin Therapy Rarely Causes Symptomatic Side Effects. (2018) (22)
EXERCISE AFTER MYOCARDIAL-INFARCTION REDUCES MORTALITY - EVIDENCE FROM RANDOMIZED CONTROLLED TRIALS (RCTS) (1984) (21)
Identification of host–pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank (2019) (21)
Physical Activity, Sedentary Leisure Time, Circulating Metabolic Markers, and Risk of Major Vascular Diseases (2019) (21)
Impact of CKD on Household Income (2017) (20)
Reliable measurement of glycated hemoglobin in frozen blood samples: implications for epidemiologic studies. (2002) (20)
Approaches to minimising the epidemiological impact of sources of systematic and random variation that may affect biochemistry assay data in UK Biobank. (2020) (20)
A Platform for the Remote Conduct of Gene-Environment Interaction Studies (2013) (19)
Interleukin-6, C-reactive protein, fibrinogen, and risk of recurrence after ischaemic stroke: Systematic review and meta-analysis (2021) (18)
Study design of the International Stroke Trial (IST), baseline data, and outcome in 984 randomised patients in the pilot study. (1996) (18)
Stabilization of homocysteine in unseparated blood over several days: a solution for epidemiological studies. (2003) (18)
Multiple QTL influence the serum Lp(a) concentration: a genome-wide linkage screen in the PROCARDIS study (2007) (18)
Improving public health by improving clinical trial guidelines and their application (2017) (17)
PROBLEMS WITH MAILED BLOOD IN LARGE-SCALE EPIDEMIOLOGIC STUDIES AND METHODS OF CORRECTION (1993) (16)
CHOLESTEROL LOWERING TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT (1993) (16)
General and Abdominal Adiposity and Mortality in Mexico City (2019) (15)
Helicobacter pylori screening and gastric cancer (1996) (14)
Pregnancy, pregnancy loss and the risk of diabetes in Chinese women: findings from the China Kadoorie Biobank (2019) (14)
Systemic inflammation is associated with incident stroke and heart disease in East Asians (2020) (14)
The exon 1–8C/G SNP in the PSMA6 gene contributes only a small amount to the burden of myocardial infarction in 6946 cases and 2720 controls from a United Kingdom population (2008) (14)
Effects on ventricular arrhythmias of oral captopril and of oral mononitrate started early in acute myocardial infarction: results of a randomised placebo controlled trial. (1993) (14)
Re-survey of the Whitehall Study of London Civil Servants: Changes in Risk Factors for Cardiovascular Disease during 29 Years of Follow-up (2000) (13)
Sex differences in hospital mortality following acute myocardial infarction in China: findings from a study of 45 852 patients in the COMMIT/CCS-2 study (2011) (12)
Strategic Need for Large Prospective Studies in Different Populations. (2019) (12)
Reliable and unbiased assessment of the effects of calcium antagonists: importance of minimizing both systematic and random errors (1997) (12)
Effects of Omega-3 Fatty Acid Supplements on Arrhythmias. (2020) (11)
The EBCTCG Overview of Adjuvant Therapy of Breast Cancer (1993) (11)
Environmental and genetic risk factors for myopathy in Chinese participants from HPS2-THRIVE (2012) (11)
Misrepresentation of statin safety evidence (2014) (11)
Efficacy and safety of cholesterol-lowering treatment – Authors' reply (2006) (10)
Dairy consumption and risks of total and site-specific cancers in Chinese adults: an 11-year prospective study of 0.5 million people (2022) (10)
Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes (2019) (10)
Interpretation of IST and CAST stroke trials (1997) (10)
Carotid Intima‐Media Thickness but Not Carotid Artery Plaque in Healthy Individuals Is Linked to Lean Body Mass (2019) (9)
Risks and benefits of calcium antagonists (1995) (9)
The Anglo-Scandinavian Cardiac Outcomes Trial: Blood pressure-lowering limb (ASCOT-BPLA): effects in patients with type 2 diabetes (2006) (8)
IV NITROGLYCERIN (NG) AND NITROPRUSSIDE (NP) THERAPY IN ACUTE MYOCARDIAL-INFARCTION REDUCES MORTALITY - EVIDENCE FROM RANDOMIZED CONTROLLED TRIALS (RCTS) (1985) (8)
Adverse events associated with un-blinded, but not with blinded, statin therapy in the Anglo- Scandinavian Cardiac Outcomes Trial (2017) (8)
Tricuspid incompetence complicating acute myocardial infarction. (1977) (8)
Self‐Rated Health Status and Risk of Ischemic Heart Disease in the China Kadoorie Biobank Study: A Population‐Based Cohort Study (2017) (8)
Large-scale randomized evidence: Trials and meta-analyses of trials (2010) (8)
United Kingdom Biobank (UK Biobank): JACC Focus Seminar 6/8. (2021) (8)
Making randomised trials larger: a simple solution? (1995) (7)
Are statins useful in patients with advanced chronic kidney disease? - Authors' reply. (2016) (7)
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis (2022) (7)
HEPARIN IN THE PRESENCE OR ABSENCE OF ANTIPLATELET THERAPY - AN OVERVIEW OF RANDOMIZED TRIALS IN ACUTE MYOCARDIAL-INFARCTION (1992) (7)
Aspirin use and chronic diseases (1990) (7)
Isis-4 pilot study: Serial hemodynamic changes with oral captopril and oral isosorbide mononitrate in a randomized double-bund trial in acute myocardial infarction (1991) (7)
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease (2021) (7)
Low cholesterol and coronary heart disease: Authors' reply (1991) (7)
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease (2019) (6)
The Impact of Genetic Variants Related to LDL-cholesterol on Risk of Ischemic Stroke and Coronary Heart Disease (2012) (6)
Approaches to minimising the epidemiological impact of sources of systematic and random variation that may affect biochemistry assay data in UK Biobank (2021) (6)
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease (2019) (6)
Abstract 17123: Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels (2010) (5)
Low-intensity daily smoking and cause-specific mortality in Mexico: prospective study of 150 000 adults (2021) (5)
Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare Costs (2016) (5)
Abdominal and gluteo-femoral markers of adiposity and risk of vascular-metabolic mortality in a prospective study of 150 000 Mexican adults (2021) (5)
Genotyping, sequencing and analysis of 140,000 adults from the Mexico City Prospective Study (2022) (5)
Heart protection study finds simvastatin reduces vascular risk in a wide range of high-risk patients. (2002) (5)
GISSI-2: 10% reduction in mortality with heparin in acute myocardial infarction? (1990) (5)
Longitudinal Changes of Cardiac and Aortic Imaging Phenotypes Following COVID-19 in the UK Biobank Cohort (2021) (5)
Identification of host–pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank (2022) (4)
Fresh fruit consumption in relation to incident diabetes and diabetic vascular complications: findings from the China Kadoorie Biobank Study (2016) (4)
AFTER ISIS-3 - REPLY (1992) (4)
PEP trial - Reply (2000) (4)
Immediate versus deferred zidovudine (1993) (4)
Holter monitoring of ventricular arrhythmias in a randomised, controlled study of intravenous streptokinase in acute myocardial infarction. (1991) (4)
COMMIT/CCS-2 Clopidogrel and Metoprolol in Myocardial Infarction Trial/Second Chinese Cardiac Study (2005) (4)
Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes (2022) (4)
Orthopaedic surgeons and thromboprophylaxis (1991) (4)
Survival in relation to angina symptoms and diagnosis among men aged 70–90 years: the Whitehall Study (2007) (4)
MRC/BHF heart protection study (HPS): Mortality, cancer incidence and major vascular events during 4 years post-trial follow-up of HPS (2007) (4)
C-reactive protein in the Heart Protection Study – Authors' reply (2011) (4)
HISTAMINE-H2 ANTAGONISTS IN ACUTE UPPER GASTROINTESTINAL HEMORRHAGE - REPLY (1986) (4)
Association of Kidney Function With NMR-Quantified Lipids, Lipoproteins, and Metabolic Measures in Mexican Adults (2021) (4)
RANDOMIZED FACTORIAL TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL INFARCTION (1987) (4)
RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION (1987) (3)
Vehement agreement on new models? (2013) (3)
Presentation and analysis of the results of clinical trials in cardiovascular disease (1981) (3)
Blood pressure and the risk of recurrent vascular disease (1998) (3)
After ISIS-3 (1992) (3)
Mechanisms for the early mortality reduction produced by beta blockade in acute myocardial infarction (1988) (3)
ISIS-4 - REPLY (1995) (3)
Sensible guidelines for clinical trials: are current European regulations 'a gift to America'? Interview by Barry Shurlock. (2013) (3)
O3-5.2 UK biobank: the need for large prospective epidemiological studies (2011) (3)
No Impact of KIF6 Genotype on Vascular Risk or Statin Benefit in the Heart Protection Study (2009) (3)
Lessons from the controversy over statins – Authors’ reply (2016) (3)
Excess risk of major vascular diseases associated with airflow obstruction: a 9-year prospective study of 0.5 million Chinese adults (2018) (3)
ISIS-4 (1995) (3)
Perioperative Rosuvastatin in Cardiac Surgery REPLY (2016) (3)
Abstract 16532: Impact of Systolic Blood Pressure on Cardiovascular Disease in a Chinese Population: A Mendelian Randomization Study (2014) (3)
Comments on the MRC/BHF Heart Protection Study (2003) (3)
The HEV Ventilator. (2020) (3)
Glucose-insulin-potassium infusion in acute myocardial infarction. (1983) (3)
Extended data: Statistical investigation of the UK Biobank biochemistry assays quality procedures (2020) (2)
ISIS-2 - A LARGE RANDOMIZED TRIAL OF INTRAVENOUS STREPTOKINASE AND ORAL ASPIRIN IN ACUTE MYOCARDIAL-INFARCTION (1989) (2)
Dose-dependent effects of folic acid on plasma homocysteineConcentrations. A meta-analysis of the randomised trials (2005) (2)
Association of heart rate and diabetes among 0.5 million adults in the China Kadoorie biobank: Results from observational and Mendelian randomization analyses. (2021) (2)
Genome-wide association scans identify novel loci that influence lipid levels and risk of coronary artery disease (2007) (2)
Economic evaluation of the Heart Protection Study (2003) (2)
Impact of renal function on the effects of reducing LDL cholesterol with statin-based regimens: meta-analysis of individual data from 28 randomised trials. (2016) (2)
Utility of single versus sequential measurements of risk factors for prediction of stroke in Chinese adults (2021) (2)
Quantitative Trait Genetic Linkage Analysis of Body Mass Index in Familial Coronary Artery Disease (2008) (2)
Benefits of lowering cholesterol in chronic kidney disease – Authors' reply (2011) (2)
Cholesterol and total mortality (1992) (2)
Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial (2022) (2)
Genetic loci influencing C-reactive protein levels and coronary heart disease risk: results of genetic association and Mendelian randomisation study with meta-analysis in 80 614 people (2009) (2)
Investigating modifications to participant information materials to improve recruitment into a large randomized trial (2019) (2)
UK Biobank: a globally important resource for cancer research (2022) (2)
Safety and efficacy of statins – Authors' reply (2017) (2)
Body-mass index, abdominal adiposity, and cardiovascular risk – Authors' reply (2011) (2)
Challenges and Opportunities in IBD Clinical Trial Design. (2021) (2)
Interethnic analyses of blood pressure loci in populations of East Asian and European descent (2018) (2)
The generation and overestimation of the association between birth weight and blood pressure in epidemiological studies: A meta-analysis of the fetal-origins hypothesis of chronic disease (2002) (2)
Association of Blood Pressure With Cause-Specific Mortality in Mexican Adults (2020) (2)
06 The pulmonary embolism prevention (PEP) trial: effects of low-dose aspirin on major vascular events in hip fracture surgical patients (1999) (2)
Outdoor temperature, blood pressure and cardiovascular disease mortality among people with diagnosed cardiovascular diseases: findings from the China Kadoorie Biobank (2014) (2)
Back to the future: The urgent need to re-introduce streamlined trials (2018) (2)
Changes in the Diagnosis and Management of Diabetes in Mexico City Between 1998–2004 and 2015–2019 (2021) (2)
Lack of adverse effect of statin therapy on common muscle-related adverse events (2015) (2)
The pulmonary embolism prevention (PEP) trial: Effects of low-dose aspirin on major vascular events in patients with hip fracture (1999) (1)
Abstract 11959: The Impact of Genetic Variants Related to LDL-cholesterol on Risk of Ischemic Stroke and Coronary Heart Disease (2012) (1)
New Horizons: the value of UK Biobank to research on endocrine and metabolic disorders (2022) (1)
Counterpoint: "streamlined" does not mean simple. (2013) (1)
Body mass index and COVID-19 mortality: prospective study of 120 000 Mexican adults (2022) (1)
COMMIT/CCS-2 studies – Authors' reply (2006) (1)
Mthfr c677t genotype is not associated with ischaemic heart disease and stroke in a large prospective study in china (2014) (1)
Tobacco smoking and risks of >470 diseases in China: a prospective cohort study (2022) (1)
Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes (2022) (1)
Risks of Stroke and Heart Disease Following Hysterectomy and Oophorectomy in Chinese Premenopausal Women (2022) (1)
Title : Polymorphisms in the WNK 1 Gene Are Associated with Blood Pressure Variation and Urinary Potassium Excretion (2009) (1)
A meta-analysis of the association between birthweight and coronary heart disease (2006) (1)
Facts and figures from the meta-analyses in breast cancer (1998) (1)
Heart protection study. Authors' reply (2003) (1)
Effects of Folic Acid Plus Vitamin B-12 vs Placebo in Myocardial Infarction Survivors Reply (2010) (1)
Magnesium in acute myocardial infarction (1997) (1)
MRC/BHF Heart protection study. Authors' reply (2002) (1)
Improvements in Modeling of Pulmonary Uptake of Toxicants. (1994) (1)
OVERVIEW OF THE RANDOMIZED CONTROLLED TRIALS OF PERI-OPERATIVE LOW-DOSE HEPARIN (1985) (1)
ISIS-3 - REPLY (1991) (1)
Aspirin in the primary prevention of vascular disease – ATT secretariat's reply (2009) (1)
Genetically Predicted Differences in Systolic Blood Pressure and Risk of Cardiovascular and Noncardiovascular Diseases: A Mendelian Randomization Study in Chinese Adults (2023) (1)
THE RELATIONS OF SERUM-CHOLESTEROL, BLOOD-PRESSURE, AND SMOKING HABIT TO CORONARY HEART-DISEASE IN A POPULATION WITH LOW MEAN CONCENTRATIONS OF SERUM-CHOLESTEROL (1989) (1)
Randomized trial of cholesterol-lowering and antioxidant vitamins in 7,000 high-risk individuals with LDL cholesterol below 120 mg/dl (2002) (1)
Unravelling the fetal origins hypothesis. Authors' reply (2002) (1)
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (2022) (1)
In search of genetic precision. Authors' reply (2003) (1)
Cholesterol, statins, and mortality – Authors' reply (2008) (1)
Modification effect of ideal cardiovascular health metrics on genetic association with incident heart failure in the China Kadoorie Biobank and the UK Biobank (2021) (1)
Cholesterol fractions and apolipoprotiens are strong predictors of heart disease mortality in older men (2007) (1)
Efficacy and safety of more intensive lowering of LDL cholesterol – Authors' reply (2011) (1)
New analyses of Heart Protection Study (2004) (1)
Global priorities for large-scale biomarker-based prospective cohorts (2022) (1)
In search of genetic precision (2003) (1)
Body Composition and Risk of Vascular‐Metabolic Mortality Risk in 113 000 Mexican Men and Women Without Prior Chronic Disease (2023) (0)
Adiposity and NMR-measured lipid and metabolic biomarkers among 30,000 Mexican adults (2022) (0)
P70 Calibrating Cardiovascular Disease Policy Model Using Large Cohort Data (2022) (0)
Genetic variation in lipid response to statin therapy in 18,705 participants in the heart protection study (2011) (0)
P3824Body composition and mortality from vascular or metabolic causes among 150,000 participants in the Mexico City Prospective Study (2019) (0)
BRITISH CARDIOLOGY British Heart Foundation surveys ( 1987 and 1989 ) of United Kingdom treatment policies for acute myocardial infarction (2004) (0)
Vitamin D and Risk of Cardiovascular and Non-Cardiovascular Mortality: A Prospective Cohort Study and Meta-Analysis (2011) (0)
Randomization versus Real-World Evidence. Reply. (2020) (0)
Gender difference in prognosis after acute MI among 45,852 Chinese patients in COMMIT/CCS2 (2009) (0)
Peter Sleight (2020) (0)
Clopidogrel and metoprolol in myocardial infarction – Authors' reply (2006) (0)
OVERVIEW OF MORTALITY RESULTS FROM ALL RANDOMIZED CONTROLLED TRIALS OF EARLY IV BETA-BLOCKADE AFTER MYOCARDIAL-INFARCTION (1986) (0)
COMMON GENETIC VARIANTS ASSOCIATED WITH LOW Lp(a) KRINGLE-IV COPY NUMBER, HIGH Lp(a) CONCENTRATION, AND INCREASED RISK OF CORONARY HEART DISEASE (2010) (0)
Independent relevance of renal function for coronary artery disease (2010) (0)
Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China: findings from the China Biobank study of 0.5 million people (2013) (0)
Adiposity Blood pressure in relation to general and central adiposity among 500 000 adult Chinese men and women (2015) (0)
Prevalence, treatment and control of hypertension in middle-aged Mexican adults (2015) (0)
Nature Genetics | Article (2015) (0)
Safety of long-term simvastatin discontinuation Reply (2012) (0)
Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults (2019) (0)
New analyses of Heart Protection Study - Reply (2004) (0)
OC04_04 Extreme Cardiac and Renal Mortality From Diabetes: 12-Year Blood-Based Prospective Study of 150,000 Mexican Adults (2016) (0)
1 1 2 Multimodal population brain imaging 3 in the UK Biobank prospective epidemiological study 4 5 (2017) (0)
Abstract 2076: Common Genetic Variants Associated With Higher Lp(a) Concentrations and Increased Risk of Coronary Heart Disease (2009) (0)
Antibiotics in the prevention of coronary heart disease: review of the randomised trials (2001) (0)
Large-scale evidence from randomised placebo-controlled trials has shown that statin therapy (2017) (0)
of cardiovascular disease Aspirin and other antiplatelet agents in the secondary and primary prevention (2011) (0)
Development and external validation of a breast cancer absolute risk prediction model in Chinese population (2021) (0)
Strategies for Chronic Disease Control: Royal Society Rory Collins and Sir David Weatherall (2017) (0)
Cognitive aging and the incidence of cardiovascular events and diabetes: a meta-analysis of the HPS, SEARCH and HPS2-THRIVE studies (2015) (0)
Adiposity, Blood Pressure, and Incidence of Stroke Subtypes Among 0.5 Million Adult Chinese With 7 Years of Follow-Up (2014) (0)
Abstract 10585: Vitamin D and Risk of Cardiovascular and Non-Cardiovascular Mortality: A Prospective Cohort Study and Meta-Analysis (2011) (0)
Randomized trial of cholesterol-lowering, and of antioxidant vitamins, in 6,000 people with diabetes mellitus (2002) (0)
Impact of diabetes duration and glycoslyated haemoglobin on 14-year cause-specific mortality among 150,000 Mexican adults (2018) (0)
PEP trial (2000) (0)
Early breast cancer - the randomised evidence (1999) (0)
N-BNP and vascular disease among 20,536 patients in the MRC/BHF Heart Protection Study (2005) (0)
1 PROTOCOL AND QUALITY ASSURANCE FOR CAROTID IMAGING IN 100 , 000 1 PARTICIPANTS OF UK BIOBANK : DEVELOPMENT AND ASSESSMENT 2 3 4 (2017) (0)
Systemic inflammation is associated with incident stroke and heart disease in East Asians (2020) (0)
Benefits of reducing LDL cholesterol among 18,686 patients with diabetes: Meta-analysis of 14 radomized trials of a statin versus control (2006) (0)
Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial (2005) (0)
Vitamin E supplementation inhibits LDL oxidation in patients at increased risk of coronary heart disease (1993) (0)
The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions (2020) (0)
Mid-1970's imbalance in zircon supply and demand (1975) (0)
Sex-specific relevance of diabetes to occlusive vascular and other mortality: Meta-analysis of individual data from 68 prospective studies with 77,000 deaths among 1 million adults (2018) (0)
Paraoxonase polymorphisms and coronary heart disease. Authors' reply (2004) (0)
Increased risk of early and late mortality with first degree heart block in patients with acute myocardial infarction (1990) (0)
Antiplatelet prophylaxis: Authors' reply (1994) (0)
P2-41 Prevalence of smoking and its association with mortality in China: findings of the Kadoorie Biobank Study of 0.5 million people (2011) (0)
LOW CHOLESTEROL AND CORONARY HEART-DISEASE - REPLY (1991) (0)
ASSOCIATION STUDY OF CORONARY ARTERY DISEASE (CAD) USING HUMANCVD 50K CHIP (2009) (0)
Publisher Correction: Systemic inflammation is associated with incident stroke and heart disease in East Asians (2020) (0)
Effects of cholesterol-lowering therapy and antioxidant vitamin supplementation on the risk of stroke (2002) (0)
Radiotherapy and surgery in early breast cancer - Reply (1996) (0)
Diabetes and infectious disease mortality in Mexico City (2023) (0)
ISIS COLLABORATIVE GROUP - RANDOMIZED TRIAL OF EARLY IV ATENOLOL IN MYOCARDIAL-INFARCTION - SUBSIDIARY ANALYSES (1986) (0)
Publisher Correction: Utility of single versus sequential measurements of risk factors for prediction of stroke in Chinese adults (2021) (0)
Hypertension and age-specific burden of carotid atherosclerosis in China: results from 25,000 individuals in the China Kadoorie biobank study (2015) (0)
83 Determinants of post-operative atrial fibrillation in 1613 patients undergoing coronary artery bypass grafting in the statin therapy in cardiac surgery (stics) trial (2022) (0)
Maintaining healthy sleep patterns and frailty transitions: a prospective Chinese study (2022) (0)
Detecting cognitive effects of vascular event prevention in randomized trials (2019) (0)
Age-specific relation of blood pressure to vascular and non-vascular chronic disease in China: a prospective study of 0.5 million adults (2018) (0)
Adiposity and risk of ischaemic and haemorrhagic stroke in Chinese men and women: a prospective study of 0.5 million adults (2018) (0)
Randomized trial of cholesterol-lowering and antioxidant vitamins in 5,000 women at high-risk of coronary heart disease (2002) (0)
Physical activity and sedentary leisure time and their associations with BMI , waist circumference , and percentage body fat in 0 . 5 million adults : the China Kadoorie Biobank study 1 – 3 (2013) (0)
Prevalence and determinants of COPD in 320,000 never smokers in China: Results from the China Kadoorie Biobank study (2013) (0)
Does CRP Play a Causal Role in the Development of Coronary Heart Disease: Results of a Mendelian Randomisation Experiment Involving 128,935 People (2009) (0)
Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease (2019) (0)
P661Associations of sedentary behaviour with myocardial infarction and stroke: findings from a 10-year prospective study of 0.5 million chinese adults (2018) (0)
Risk of cardiovascular events following COPD hospitalisation: Findings from the China Kadoorie Biobank cohort study (2015) (0)
Large-scale test of association between myocardial infarction, plasma lipid levels and apolipoprotein E e2/e3/e4 polymorphism in about 11,000 cases and controls (2000) (0)
Efficacy and safety of early and late treatment with streptokinase, aspirin or both in patients with acute myocardial infarction: ISIS-2 results and further analyses (1990) (0)
Renal and vascular diseases are under-counted as underlying causes of death in diabetic populations: Prospective study of 150,000 Mexicans followed for 10 years (2015) (0)
P2-66 Physical activity and its associations with prevalence of overweight, hypertension, diabetes and ischaemic heart disease in the Kadoorie Biobank study of 0.5 million people in China (2011) (0)
Author Correction: Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors (2020) (0)
Removing unnecessary obstacles to randomised trials (2013) (0)
Critical role of TGF-β1-induced peritoneal metastasis of ovarian cancer cell through up-regulation of TGF-β type I receptor (2016) (0)
Blood glucose levels at baseline and incidence of type 2 diabetes: a prospective cohort study of 0.5 million adults in the China Kadoorie Biobank (2014) (0)
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial (2023) (0)
Publisher Correction: Systemic inflammation is associated with incident stroke and heart disease in East Asians (2020) (0)
P2-116 Adiposity and its contribution to individual and regional differences in blood pressure: The Kadoorie Biobank Study of 0.5 million people in China (2011) (0)
Edinburgh Research Explorer UK Biobank: Opportunities for cardiovascular research (2017) (0)
Aspirin in the primary prevention of vascular disease. Authors' reply (2009) (0)
Perioperative Rosuvastatin in Cardiac Surgery. (2016) (0)
DIURETICS IN PREGNANCY - OVERVIEW OF RANDOMIZED TRIALS - IMPLICATIONS FOR TRIALS OF OTHER AGENTS IN PREGNANCY (1984) (0)
Table 1. Comparison of results for samples extracted with the MagNA Pure and the Qiagen BioRobot 9604. a (2002) (0)
Associations of random plasma glucose with risk of 1 cardiovascular disease among 467 000 Chinese adults 2 without known diabetes: a 7-year prospective study 3 (2016) (0)
Smoking and mortality in China: A prospective study of 9351 middle-aged adults in Shanghai, with a 16-year follow-up (2000) (0)
Abstract 10667: Mendelian Randomization of Lp(a) Levels and Coronary Disease Risk (2011) (0)
Diabetes in relation to incidence of cardiovascular disease in Chinese men and women: a prospective cohort study of 0.5 million adults with 7 years of follow-up (2014) (0)
P1-412 Stability of biomarkers in plasma frozen at various temperatures for several years: implications for prospective epidemiological studies (2011) (0)
Questioning statin therapy for older patients – Authors' reply (2020) (0)
Large Simple Trials (2004) (0)
Papillary Muscle Hypothesis of Idiopathic Left Ventricular Tachycardia (2016) (0)
Centres of Excellence: The clinical trial service Unit and epidemiological studies unit, university of Oxford, Oxford, United Kingdom (2008) (0)
Healthy lifestyle, DNA methylation age acceleration, and incident risk of coronary heart disease (2023) (0)
Frozen Blood Samples: (2002) (0)
Aspirin use and chronic diseases (III) (1990) (0)
Abstract # 17097: Lipoprotein(a) Genetic Variants Associated with Risk of Atherothrombotic Disease in 14,465 Participants from the Heart Protection Study (2010) (0)
The burden of hypertension in china in the 21st century: findings from the china kadoorie biobank study of 0.5 million chinese adults (2014) (0)
Abstract 16588: Adiposity, Blood Pressure, and Incidence of Stroke Subtypes Among 0.5 Million Adult Chinese With 7 Years of Follow-Up (2014) (0)
Periodontitis, Atherosclerotic Cardiovascular Disease and Vitamin D (2009) (0)
TRIALS OF ANTIPLATELET THERAPY - REPLY (1994) (0)
Blood pressure and vasculo-metabolic mortality in Mexico City: 12-year follow-up of 150,000 adults. (2017) (0)
Null Relationship of BMI to Diabetes Prevalence at Baseline in the Mexico City Prospective Study of 150,000 Adults with Stored Blood and 10-year Mortality Follow-Up. (2014) (0)
Pulmonary embolism:identification, clinical features and management (2009) (0)
Blood pressure and death from vascular and metabolic diseases in Mexico City: 12-year follow-up of 150,000 adults (2017) (0)
Antiplatelet prophylaxis. The same for men and women [2] (1994) (0)
Association of RandomPlasma Glucose Levels With the Risk for Cardiovascular Disease Among Chinese AdultsWithout KnownDiabetes (2016) (0)
A meta-analysis of the association between birthweight and subsequent cholesterol level (2003) (0)
A Loss-of-Function Variant in CETP Is Associated With Altered Lipid Metabolism but Not With Cardiovascular Disease Incidence in Chinese Adults (2016) (0)
C-reactive protein in the Heart Protection Study Reply (2011) (0)
Safety of long-term simvastatin discontinuation – Authors' reply (2012) (0)
Impact of the COVID-19 pandemic on admission rates for, and management of, acute coronary syndromes in England. (2020) (0)
Common Genetic Variants Associated With Higher Lp(a) Concentrations and Increased Risk of Coronary Heart Disease (2009) (0)
N-terminal pro-B-type natriuretic peptide and vascular disease among 20,536 patients in the MRC/BHF heart protection study (2005) (0)
P6282Adiposity and vascular-metabolic mortality among 150,000 Mexican adults followed for 15 years (2018) (0)
COPD and risk of cardiovascular disease: A prospective study of 0.5M Chinese adults (2015) (0)
Benefits of thrombolysis (1990) (0)
Re: Chronic aspirin therapy is effective - if you massage the data sufficiently (2017) (0)
Current treatments of cardiovascular diseases are unlikely to produce more than moderate reductions in mortality (1985) (0)
REDUCTION IN MORTALITY AFTER MYOCARDIAL-INFARCTION BY ACUTE INTERVENTION (1983) (0)
Trials of antiplatelet therapy: Authors' reply. (1994) (0)
Body mass index during early adulthood in relation to risk of diabetes in later life among Chinese men and women (2015) (0)
Weight loss in a cardiovascular trial population identifies people at future risk of dementia (2022) (0)
Blood Pressure, Cholesterol and Common Causes of Death: Towards the Real Relationships (2001) (0)
The Controversy Surrounding Surgical Care Improvement Project-Venous Thromboembolism Process Measures (2017) (0)
Cloud gazing: demonstrating paths for unlocking the value of cloud genomics through cross-cohort analysis (2022) (0)
Abstract 17979: A Genome-Wide Association Study of Risk of Coronary Artery Disease in European and South Asian Populations (2010) (0)

This paper list is powered by the following services:

Other Resources About Rory Collins

en.wikipedia.org

What Schools Are Affiliated With Rory Collins?

Rory Collins is affiliated with the following schools: